Try our Advanced Search for more refined results
May 17, 2013
Purdue Pharma L.P. et al v. Amneal Pharmaceuticals, LLC
Case Number:
1:13-cv-03372
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 08, 2016
Fed. Circ. Won't Revive OxyContin Anti-Abuse Patent
The Federal Circuit on Friday upheld a district court's finding that a Purdue Pharma patent for an abuse-resistant variety of OxyContin is invalid as obvious, sealing a win for generic-drug maker Amneal Pharmaceuticals.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login